Evidence map›Paper›PMID 23212373›Full record

ArticleNature communications2012

The RB family is required for the self-renewal and survival of human embryonic stem cells.

Jamie F Conklin, Julie Baker, Julien Sage

Abstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. International journal of molecular sciences · 2023
    Article
  10. International journal of biological sciences · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. G1-phase progression in pluripotent stem cells.Cellular and molecular life sciences : CMLS · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jamie F ConklinDepartment of Pediatrics, Stanford Medical School, Stanford, California 94305, USA.
Julie Baker
Julien Sage
Stanford Medicine · USInstitute for Stem Cell Biology and Regenerative Medicine · IN

Funding

GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
NIGMS NIH HHS 5 T32 GM007790NIGMS NIH HHS T32 GM007790
6 · The paper itself

Abstract

The mechanisms ensuring the long-term self-renewal of human embryonic stem cells are still only partly understood, limiting their use in cellular therapies. Here we found that increased activity of the RB cell cycle inhibitor in human embryonic stem cells induces cell cycle arrest, differentiation and cell death. Conversely, inactivation of the entire RB family (RB, p107 and p130) in human embryonic stem cells triggers G2/M arrest and cell death through functional activation of the p53 pathway and the cell cycle inhibitor p21. Differences in E2F target gene activation upon loss of RB family function between human embryonic stem cells, mouse embryonic stem cells and human fibroblasts underscore key differences in the cell cycle regulatory networks of human embryonic stem cells. Finally, loss of RB family function promotes genomic instability in both human and mouse embryonic stem cells, uncoupling cell cycle defects from chromosomal instability. These experiments indicate that a homeostatic level of RB activity is essential for the self-renewal and the survival of human embryonic stem cells.

Indexed as

AnimalsCell CycleCell DeathCell SurvivalCrk-Associated Substrate ProteinCyclin-Dependent Kinase Inhibitor p21Embryonic Stem CellsFibroblastsHumansMiceRetinoblastoma-Like Protein p107Retinoblastoma ProteinTumor Suppressor Protein p53Crk-Associated Substrate ProteinCyclin-Dependent Kinase Inhibitor p21Retinoblastoma-Like Protein p107Retinoblastoma ProteinTumor Suppressor Protein p53

Identifiers

PMID23212373
OpenAlexW2051445779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.